In a Victory for the Free Market, FDA Approves New Schizophrenia Drug
Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.
Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.
Season 2, Episode 4 Podcasts
Also: Could legalizing the sale of kidneys and other organs save lives?
This legislation could save many lives by giving tax credits to kidney donors. But it would not be as good as full legalization of organ sales.
Season 2, Episode 3 Health Care
Part Two: How Certificate of Need laws limit access to health care, and why those rules can be so difficult to dislodge.
Despite anti-immigrant rhetoric, the foreign-born account for nearly 20 percent less public health spending than those born in America.
This Kentucky Republican won't stop until he finds a state willing to make legal room for ibogaine, a drug he calls "God's medicine."
Season 2, Episode 2 Health Care
Too often, it's government bureaucrats acting under the influence of special interests and against the wishes of doctors and patients, with sometimes tragic results.
An FDA advisory committee concluded that MDMA's benefits had not been shown to outweigh its risks.
Each candidate made some good points about reproductive freedom and each told some major whoppers.
t makes case that enormous benefits of organ markets create a strong presumption in favor of legalization that standard objections don't even come close to overcoming.
Season 2, Episode 1 Free Markets
Cuban's Cost Plus Drugs project brings a bit of free market flair to the health care industry, but the lack of meaningful price signals is only part of the problem.
The host of Why We Can't Have Nice Things returns to discuss the podcast's second season, which focuses on how government makes Americans poorer and sicker.
Season 2 Podcasts
A new season brings six new stories about how the government is making Americans poorer and sicker.
Americans need a politician dedicated to unwinding decades of government interventions that have driven up the cost of middle-class living.
Wandercraft, the French company that developed the exoskeleton suit, recently got FDA approval to use them for stroke rehab in the U.S.
There seems to be general bipartisan agreement on keeping a majority of the cuts, which are set to expire. They can be financed by cleaning out the tax code of unfair breaks.
Georgia parents were accused of child abuse after they took their daughter to the doctor. Does the state's story add up?
Georgia parents were accused of child abuse after they took their daughter to the doctor. Does the state's story add up?
A widely cited study commits so many egregious statistical errors that it's a poster child for junk science.
Two years after the Dobbs decision, Americans are increasingly concerned with how abortion bans affect women with wanted pregnancies.
Thanks to clever inventions and investments from venture capitalists, the average American can head to CVS and purchase kits to test for drug use, sexually transmitted diseases, AIDs, diabetes, blood pressure and cholesterol.
As the DEA relentlessly tightens regulations on pain meds, the FDA refuses to approve a safer alternative already being used in similar countries.
It's the contraception mandate in reverse, with no exception for religious employers.
Bhattacharya explains the stakes of Murthy v. Missouri, the politicization of medical research, and his RFK Jr. endorsement.
So many problems would have disappeared if we had treated them like a normal product.
Artificial intelligence is helping humans get medical care, organize their finances, and plan vacations.
A new lawsuit argues the state's requirement that doctors must be licensed in California to do remote consultations with patients there is unconstitutional.
Plus, an AI-generated version of the same article
The war on drugs meets abortion...
There's an easy way to lower the cost of next-generation weight-loss drugs.
Price controls lead to the misallocation of resources, shortages, diminished product quality, and black markets.
With help from artificial intelligence, doctors can focus on patients.
New red tape will result in fewer safe and effective diagnostic tests.
There are no good sides in today's Supreme Court case concerning the EMTALA and abortion.
Certificate of need laws were supposed to ensure high-quality health care in rural places. Instead, they allowed hospitals to veto potential competitors.
I'm the DEA's poster child for prescription stimulant abuse: a 30-something adult who needs a telehealth psychiatrist and can't remember what day the garbage truck comes.
Giving kidney donors a $50,000 tax credit isn't as good as full legalization of organ markets would be. But it would still be a major step in the right direction.
The author of The Anxious Generation argues that parents, schools, and society must keep kids off of social media.
After botching COVID test approvals, the Food and Drug Administration wants power over thousands of other tests.
Examining the mixed legacy of a fighter for patient autonomy.
I shouldn't have to spend so much money on an accountant every year. But I don't really have a choice.
A Biden administration ploy could give the federal government control over drug prices.
Philip Esformes was sentenced for charges on which a jury hung. After receiving a commutation, the federal government vowed to try to put him back in prison.
The reality raises questions about the kind of future we want to leave for the next generation.
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10